Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on Terumo Health Outcomes (THO) and Medis Medical Imaging — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
Watch the 2-minute tour · with sound

Terumo Health Outcomes and Medis Medical Imaging Enter Strategic Partnership to Enhance Cardiovascular Care in the United States

Dec 10, 2024over 1 year ago

Contract Type

partnership

BiotechnologyHealth CareMedical Device

Description

Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), and Medis Medical Imaging, a leading cardiac imaging software company, have announced a strategic partnership in the United States. The partnership aims to enhance cardiovascular care through the utilization of Terumo's ePRISM™ precision medicine software platform and Medis' Quantitative Flow Ratio (QFR) technology.

Company Information

Company

Terumo Health Outcomes (THO) and Medis Medical Imaging

About

Terumo Health Outcomes (THO) is a division of Terumo Interventional Systems (TIS) and Medis Medical Imaging is a leading cardiac imaging software company.

Predictive Intelligence
Strategic

ML-powered predictions for Terumo Health Outcomes (THO) and Medis Medical Imaging's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months